1. Market Research
Patient Centric Pharma: Restructuring business for better outcomes

Patient Centric Pharma: Restructuring business for better outcomes

  • August 2015
  • ID: 3509459
  • Format: PDF
  • Firstword Pharma

Summary

Table of Contents




Is “patient centricity” a passing fad? Experts say it’s here to stay. In fact, it’s been called a “strategic necessity.” Companies like Pfizer and Sanofi know it. Patient Centric Pharma gives you an insider’s look at how they and others are using patient centricity to build business and cement relationships, and what you need to do to compete.

Contributors include executives from Boehringer Ingelheim, Merck Serono, UCB and others. Case studies and examples are drawn from experiences at AbbVie, AstraZeneca, Novo Nordisk, and Vertex, in addition to Pfizer and Sanofi.







Top Takeaways

Meet customer expectations: See what we can learn from companies outside pharma like Amazon about customer engagement and responsiveness.
The value of patient centricity: Find out the factors that make this model the valuable modern approach to business pharma needs and not just a buzzword.
Be more relevant: Gain strategic advantage by understanding how to be more relevant to patients.
Gain organization-wide commitment: How to get support from senior management to ensure there is a “patient centricity team” and “Chief Patient Officer” in the future of your business.
Experts tell us the barriers to patient centricity: Know the internal and external barriers to patient centricity, how to overcome them, and why you should bother.
The benefits of patient collaboration: How to better collaborate with patients and benefit from the experience.
Improve product life cycle: How to use patient engagement and input throughout your organisation and across the lifecycles of your brands.



Key Issues Explored

The critical relationship between patient centricity and customer expectations in 21st century commerce.
Strategies and techniques for overcoming internal and external barriers to patient centricity.
Patient centricity is more than an attitude; it’s a pathway to valuable business information.
Patient centricity merits and requires the support of senior management and an organization-wide commitment. Have you got that at your company? If not, how can you get it?
How to measure and assess patient centricity.
Patient centricity is now a factor from early stage drug development to implementation of patient support programmes.
The future of patient centricity and how to prepare for it.
Is there a “patient centricity team” or “Chief Patient Officer” in your future? Should there be?
Patients’ expectations are growing. They’re comparing you to Amazon. Your “patient centricity” needs to keep pace.
Assess patient expectations of you and your organisation and implement the programs that will help you meet them.
What are the most important elements of a patient-centric strategy?
How to effectively leverage patient engagement and input throughout your organisation and across the lifecycles of your brands.


Who needs this report

This report will benefit anyone with responsibilities in the following areas:

Marketing

Product/Brand Management

Digital/Multichannel Marketing

Commercial Innovation/Excellence

Key Account Management

Patient Advocacy Relations

Patient Experience/Engagement

Patient Recruitment/Patient Access

Medical Communications

Medical Affairs

Lifecycle Management

Regulatory/Compliance


Contributors

AbbVie
AstraZeneca
Boehringer Ingelheim
Merck Serono
Novo Nordisk
Pfizer
Sanofi
UCB
Vertex



About FirstWord Reports

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence



FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Nano PLC Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Component ; Type ; Industry

  • $ 4550
  • April 2020
  • 213 pages

In terms of revenue, the nano PLC market was valued at US$ 3.67 Bn in 2019 and is projected to reach US$ 5.67 Bn by 2027; it is expected to grow at a CAGR of 5.7% from 2020 to 2027. The growing demand ...

Coal Tar Markets in China $ 4000 March 2020


ref:plp2015

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on